[1] Liberal R, Longhi MS, Mieli-Vergani G, et al. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol, 2011, 25:653-664. [2] Czaja AJ. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis. Autoimmunity, 2019, 12:1-17. [3] Burnevich ES, Popova EN, Ponomarev AB, et al. Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review). Ter Arkh, 2019, 91(1):89-94. [4] Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology, 1997, 25:541-547. [5] Mieli-Vergani G, Vergani D. Autoimmune liver diseases in children- what is different from adulthood? Best Pract Res Clin Gastroenterol, 2011, 25: 783-795. [6] Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol, 2003, 38:982-984. [7] Kakudo K, Li Y, Hirokawa M, et al. Diagnosis of Hashimoto's thyroiditis and IgG4-related sclerosing disease. Pathol Int, 2011, 61(4):175-183. [8] Karim F, Loeffen J, Bramer W, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J, 2016, 14:18-22. [9] Rollins-Raval MA, Felgar RE, Krasinskas AM, et al. Increased numbers of IgG4-positive plasma cells may rarely be seen in lymph nodes of patients without IgG4-related sclerosing disease. Int J Surg Pathol, 2012, 20(1):47-53. [10] Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol, 2012, 25:1181-1192. [11] Mizushima I, Yamada K, Harada K, et al. Diagnostic sensitivity of cutoff values of IgG4-positive plasma cell number and IgG4-positive/CD138-positive cell ratio in typical multiplelesions of patients with IgG4-related disease. Mod Rheumatol, 2018, 28(2):293-299. [12] Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med, 2012, 366:539-551. [13] Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48 (1): 169-176. [14] Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31: 929-938. [15] Umemura T, Zen Y, Hamano H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol, 2011, 46:48-55. [16] Canivet CM, Anty R, Patouraux S, et al. Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries. Dig Liver Dis, 2016, 48:302-308. [17] Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in 125 patients. Arthritis Rheumatol, 2015, 67:2466-2475. [18] Fengqing W, Qiang Y, Feng G, et al. Serum trypsin and TCR as novel markers for predicting disease activity in IgG4-related disease. Cent Eur J Immunol, 2014, 39(2):193-197. [19] Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis, 2015, 74(1):190-195. [20] Chung H, Watanabe T, Kudo M, et al. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int, 2010, 30:222-231. |